Evidence map›Paper›PMID 34906496›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2022

Retrospective analysis of a clinical exome sequencing cohort reveals the mutational spectrum and identifies candidate disease-associated loci for BAFopathies.

Chun-An Chen, John Lattier, Wenmiao Zhu, Jill Rosenfeld, Lei Wang, Tiana M Scott, Haowei Du, Vipulkumar Patel, Anh Dang, Pilar Magoulas and 21 more

Open access · greenAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Clonazepam repurposing inJournal of medical genetics · 2025
    Trial
  2. Article
  3. Article
  4. Loss of function of the chromatin remodeling geneProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  10. A Novel Variant in theCase reports in genetics · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. A de novo variant of BICRA results in Coffin-Siris syndrome 12.Molecular genetics & genomic medicine · 2023
    Article
  17. Review
  18. Complex Diagnostics of Non-Specific Intellectual Developmental Disorder.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 9 institutions in 1 country.

Chun-An ChenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
John LattierBaylor Genetics Laboratory, Houston, TX.
Wenmiao ZhuBaylor Genetics Laboratory, Houston, TX.
Jill RosenfeldDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
Lei WangBaylor Genetics Laboratory, Houston, TX.
Tiana M ScottTexas Children's Hospital, Houston, TX; Department of Microbiology and Molecular Biology, Graduate Studies, Brigham Young University, Provo, UT.
Haowei DuDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
Vipulkumar PatelBaylor Genetics Laboratory, Houston, TX.
Anh DangBaylor Genetics Laboratory, Houston, TX.
Pilar MagoulasDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Texas Children's Hospital, Houston, TX.
Haley StreffDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Texas Children's Hospital, Houston, TX.
Jessica SebastianUPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.
Shayna SvihovecAnschutz Medical Campus, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO.
Kathryn CurryGenetics and Metabolic Department, St. Luke's Health System, Kansas City, MO.
Mauricio R DelgadoTexas Scottish Rite Hospital for Children, Dallas, TX; Department of Neurology, Medical School, University of Texas Southwestern Medical Center, Dallas, TX.
Neil A HanchardDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Texas Children's Hospital, Houston, TX.
Seema LalaniDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Texas Children's Hospital, Houston, TX.
Ronit MaromDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Texas Children's Hospital, Houston, TX.
Suneeta Madan-KhetarpalUPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.
Margarita SaenzAnschutz Medical Campus, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO.
Hongzheng DaiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Baylor Genetics Laboratory, Houston, TX.
Linyan MengDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Baylor Genetics Laboratory, Houston, TX.
Fan XiaDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Baylor Genetics Laboratory, Houston, TX.
Weimin BiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Baylor Genetics Laboratory, Houston, TX.
Pengfei LiuDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Baylor Genetics Laboratory, Houston, TX.
Jennifer E PoseyDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
Daryl A ScottDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Texas Children's Hospital, Houston, TX; Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX.
James R LupskiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Texas Children's Hospital, Houston, TX; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Department of Pediatrics, Baylor College of Medicine, Houston, TX.
Christine M EngDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Baylor Genetics Laboratory, Houston, TX.
Rui XiaoDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Baylor Genetics Laboratory, Houston, TX.
Bo YuanDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Baylor Genetics Laboratory, Houston, TX; Department of Laboratories, Seattle Children's Hospital, Seattle, WA; Department of Laboratory Medicine & Pathology, University of Washington, Seattle, WA. Electronic address: Bo.Yuan@seattlechildrens.org.
Baylor College of Medicine · USBaylor Genetics · USTexas Children's Hospital · USChildren's Hospital of Pittsburgh · USChildren's Hospital Colorado · USSaint Luke's Health System · USSeattle Children's Hospital · USTexas Scottish Rite Hospital for Children · USUniversity of Colorado Denver · US

Funding

Baylor-Johns Hopkins Center for Mendelian GeneticsUM1HG006542 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2016 to 2020
$14.5M
Individual genomic analyses to discover the molecular basis and mechanisms contributing to adult-onset diseaseK08HG008986 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI POSEY, JENNIFER ELLEN · 2017 to 2021
$831k
NHGRI NIH HHS K08 HG008986NHGRI NIH HHS UM1 HG006542
6 · The paper itself

Abstract

purposeBRG1/BRM-associated factor (BAF) complex is a chromatin remodeling complex that plays a critical role in gene regulation. Defects in the genes encoding BAF subunits lead to BAFopathies, a group of neurodevelopmental disorders with extensive locus and phenotypic heterogeneity.

methodsWe retrospectively analyzed data from 16,243 patients referred for clinical exome sequencing (ES) with a focus on the BAF complex. We applied a genotype-first approach, combining predicted genic constraints to propose candidate BAFopathy genes.

resultsWe identified 127 patients carrying pathogenic variants, likely pathogenic variants, or de novo variants of unknown clinical significance in 11 known BAFopathy genes. Those include 34 patients molecularly diagnosed using ES reanalysis with new gene-disease evidence (n = 21) or variant reclassifications in known BAFopathy genes (n = 13). We also identified de novo or predicted loss-of-function variants in 4 candidate BAFopathy genes, including ACTL6A, BICRA (implicated in Coffin-Siris syndrome during this study), PBRM1, and SMARCC1.

conclusionWe report the mutational spectrum of BAFopathies in an ES cohort. A genotype-driven and pathway-based reanalysis of ES data identified new evidence for candidate genes involved in BAFopathies. Further mechanistic and phenotypic characterization of additional patients are warranted to confirm their roles in human disease and to delineate their associated phenotypic spectrums.

Indexed as

Abnormalities, MultipleHand Deformities, CongenitalMicrognathismActinsChromosomal Proteins, Non-HistoneDNA-Binding ProteinsExomeHumansRetrospective StudiesActinsACTL6A protein, humanChromosomal Proteins, Non-HistoneDNA-Binding ProteinsBAFopathyGenotype-first approachNeurodevelopmental disorderReanalysisSWI/SNF complex

Identifiers

PMID34906496
PMCPMC8957292
OpenAlexW3216729941

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.